表紙
市場調查報告書
商品編碼
786065

血氣·電解質分析設備市場規模:各種模式,各產品,各最終用途產業分析報告,各地區預測,用途的可能性,競爭市場佔有率,預測

Blood Gas and Electrolyte Analyzers Market Size By Modality, By Product, By End-use Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2018 - 2024

出版日期: | 出版商: Global Market Insights Inc. | 英文 175 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球血氣·電解質分析設備市場相關調查,彙整市場趨勢與各市場區隔趨勢,各地區預測,加入此市場的主要企業的簡介等相關資訊。

第1章 調查方法

第2章 摘要整理

第3章 產業趨勢

  • 產業市場區隔
  • 產業趨勢
  • 影響力
  • 成長可能性分析
  • 波特分析
  • 競爭環境
  • PESTEL分析

第4章 各種模式市場

  • 主要的市場區隔趨勢
  • 台式
  • 可攜式

第5章 各產品市場

  • 主要的市場區隔趨勢
  • 血氣分析設備
  • 電解質分析設備
  • 整合分析設備
  • 消耗品

第6章 各最終用途市場

  • 主要的市場區隔趨勢
  • 中央實驗室
  • 照護現場
  • 診斷中心
  • 其他

第7章 各地區市場

  • 主要的各地區趨勢
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第8章 企業簡介

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Amgen Inc
  • Biogen Scientific
  • Bio-Rad Laboratories, Inc.
  • Danaher
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • Merck KGaA
  • PerkinElmer, Inc.
  • Qiagen
  • Thermo Fisher Scientific Inc.
  • Abbott
  • Convergent Technologies GmbH & Co. KG
  • Dalko Diagnostics
  • Edan Instruments, Inc.
  • Erba Mannheim
  • F. Hoffmann-La Roche Ltd.
  • Instrumentation Laboratory (Werfen)
  • Medica Corporation
  • OPTI Medical
  • Radiometer
  • Siemens AG
  • Tecom Analytical Systems
目錄
Product Code: 428

Title:
Blood Gas and Electrolyte Analyzers Market Size By Modality (Bench Top, Portable), By Product (Blood Gas Analyzers, Electrolyte Analyzers, Combined Analyzers, Consumables), By End-use (Central Laboratories, Point-Of-Care, Diagnostic Centers) Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, India, China, Japan, Brazil, Mexico, South Africa, Saudi Arabia), Application Potential, Competitive Market Share & Forecast, 2018 - 2024.

Blood Gas and Electrolyte Analyzers Market will exceed USD 5 billion by 2024; as per a new research report.

Escalating demand for integrated systems and high throughput coupled with growing elderly population are major impact rendering factors for business growth. The geriatric population has been on a rise. According to World Population Aging 2017, the global population aged 60 years or over was 962 million in 2017. Growing elderly population has led to an increase in the number of patients in emergency departments and critical care units receiving critical care.

Rising healthcare expenditure for the treatment of chronic diseases is expected to drive business growth over the forecast period. Moreover, escalating number of patients in intensive care units will foster business growth. In addition, growing number of well-equipped diagnostic laboratories, and increasing affordability of patients will stimulate blood and gas analyzers industry growth over the coming years.

Portable blood gas and electrolyte analyzers segment was valued at USD 2.0 billion in 2017 and is projected to grow considerably during the forecast timeline. The growth of the segment is attributed to continuous innovations and technology improvements in blood gas and electrolyte analyzer devices. Moreover, technological advancements have given rise to the development of novel devices including handheld point-of-care devices thereby, propelling segmental growth during projected timeframe.

Blood gas analyzer segment will experience 5.5% CAGR by 2024. Blood gas analyzer measures partial oxygen pressure in a patient's body. The devices are widely used in intensive care units and routine diagnosis of various diseases. Furthermore, advancements in blood gas analyzers devices and prevalence of chronic diseases are some of the contributing factors for segmental growth.

Point-of-care segment accounted for 44.6% revenue share in 2017 owing to increasing patient preference towards well-equipped advanced healthcare facilities. In addition, increasing initiatives to reduce hospital stays and to control healthcare spending are contributing factors for business expansion. Moreover, growing incidences of chronic diseases will propel segmental growth over the coming years.

U.S. blood gas and electrolyte analyzers market will witness 6.2% CAGR by 2024. The growth of the segment is attributed to rising patient awareness levels and well-established healthcare infrastructure. Furthermore, increasing government support for R&D activities will boost business growth over the coming years.

China blood gas and electrolyte analyzers was valued at USD 170.5 million in 2017 and is estimated to experience considerable growth due to rising healthcare expenditures and increasing patient awareness in the country. As per World Bank Data 2015, the R&D expenditure in China was 2.07% of GDP, comparatively higher than other countries.

Some of the prominent business players operating in blood gas and electrolyte analyzers market include Allele Biotech, Alere Medical, Bayer, Convergent Technologies, Dalko Diagnostics, Edan Instruments, Medica, Nova Stat, Radiometer Medical, Roche, Samsung Medison and Siemens. Industry competitors are mainly focusing on inorganic strategies such as partnership, merger and acquisitions to escalate their market position as well as strengthen product offerings.

Table of Contents

Chapter 1. Methodology

  • 1.1. Methodology
  • 1.2. Market definitions
  • 1.3. Forecast parameters
  • 1.4. Data sources
    • 1.4.1. Secondary
      • 1.4.1.1. Paid sources
      • 1.4.1.2. Unpaid sources
    • 1.4.2. Primary

Chapter 2. Executive Summary

  • 2.1. Blood gas and electrolyte analyzers industry 360 degree synopsis, 2013 - 2024
    • 2.1.1. Business trends
    • 2.1.2. Product trends
    • 2.1.3. Modality trends
    • 2.1.4. End-use trends
    • 2.1.5. Regional trends

Chapter 3. Blood Gas and Electrolyte Analyzers Industry Insights

  • 3.1. Industry segmentation
  • 3.2. Industry landscape, 2013 - 2024
  • 3.3. Industry impact forces
    • 3.3.1. Growth drivers
      • 3.3.1.1. Rising prevalence of chronic diseases worldwide
      • 3.3.1.2. Technological advancements
      • 3.3.1.3. Increasing demand for integrated systems
      • 3.3.1.4. Growing elderly population base in developed countries
    • 3.3.2. Industry pitfalls and challenges
      • 3.3.2.1. High product cost
      • 3.3.2.2. Complex regulatory scenario
  • 3.4. Growth potential analysis
    • 3.4.1. By product
    • 3.4.2. By modality
    • 3.4.3. By end-use
  • 3.5. Porter's analysis
  • 3.6. Competitive landscape, 2017
    • 3.6.1. Strategy dashboard
  • 3.7. PESTEL analysis

Chapter 4. Blood Gas and Electrolyte Analyzers Market, By Modality

  • 4.1. Key segment trends
  • 4.2. Bench top
    • 4.2.1. Market size, by region, 2013-2024 (USD Million)
  • 4.3. Portable
    • 4.3.1. Market size, by region, 2013-2024 (USD Million)

Chapter 5. Blood Gas and Electrolyte Analyzers Market, By Product

  • 5.1. Key segment trends
  • 5.2. Blood gas analyzers
    • 5.2.1. Market size, by region, 2013-2024 (USD Million)
  • 5.3. Electrolyte analyzers
    • 5.3.1. Market size, by region, 2013-2024 (USD Million)
  • 5.4. Combined analyzers
    • 5.4.1. Market size, by region, 2013-2024 (USD Million)
  • 5.5. Consumables
    • 5.5.1. Market size, by region, 2013-2024 (USD Million)

Chapter 6. Blood Gas and Electrolyte Analyzers Market, By End-use

  • 6.1. Key segment trends
  • 6.2. Central laboratories
    • 6.2.1. Market size, by region, 2013-2024 (USD Million)
  • 6.3. Point-of-care
    • 6.3.1. Market size, by region, 2013-2024 (USD Million)
  • 6.4. Diagnostic centers
    • 6.4.1. Market size, by region, 2013-2024 (USD Million)
  • 6.5. Others
    • 6.5.1. Market size, by region, 2013-2024 (USD Million)

Chapter 7. Blood Gas and Electrolyte Analyzers Market, By Region

  • 7.1. Abbott Laboratories
    • 7.1.1. Business overview
    • 7.1.2. Financial data
    • 7.1.3. Product landscape
    • 7.1.4. Strategic outlook
    • 7.1.5. SWOT analysis
  • 7.2. Agilent Technologies, Inc.
    • 7.2.1. Business overview
    • 7.2.2. Financial data
    • 7.2.3. Product landscape
    • 7.2.4. Strategic outlook
    • 7.2.5. SWOT analysis
  • 7.3. Amgen Inc.
    • 7.3.1. Business overview
    • 7.3.2. Financial data
    • 7.3.3. Product landscape
    • 7.3.4. Strategic outlook
    • 7.3.5. SWOT analysis
  • 7.4. Biogen Scientific
    • 7.4.1. Business overview
    • 7.4.2. Financial data
    • 7.4.3. Product landscape
    • 7.4.4. Strategic outlook
    • 7.4.5. SWOT analysis
  • 7.5. Bio-Rad Laboratories, Inc.
    • 7.5.1. Business overview
    • 7.5.2. Financial data
    • 7.5.3. Product landscape
    • 7.5.4. Strategic outlook
    • 7.5.5. SWOT analysis
  • 7.6. Danaher
    • 7.6.1. Business overview
    • 7.6.2. Financial data
    • 7.6.3. Product landscape
    • 7.6.4. Strategic outlook
    • 7.6.5. SWOT analysis
  • 7.7. F. Hoffmann-La Roche Ltd.
    • 7.7.1. Business overview
    • 7.7.2. Financial data
    • 7.7.3. Product landscape
    • 7.7.4. Strategic outlook
    • 7.7.5. SWOT analysis
  • 7.8. Illumina, Inc.
    • 7.8.1. Business overview
    • 7.8.2. Financial data
    • 7.8.3. Product landscape
    • 7.8.4. Strategic outlook
    • 7.8.5. SWOT analysis
  • 7.9. Merck KGaA
    • 7.9.1. Business overview
    • 7.9.2. Financial data
    • 7.9.3. Product landscape
    • 7.9.4. Strategic outlook
    • 7.9.5. SWOT analysis
  • 7.10. PerkinElmer, Inc.
    • 7.10.1. Business overview
    • 7.10.2. Financial data
    • 7.10.3. Product landscape
    • 7.10.4. Strategic outlook
    • 7.10.5. SWOT analysis
  • 7.11. Qiagen
    • 7.11.1. Business overview
    • 7.11.2. Financial data
    • 7.11.3. Product landscape
    • 7.11.4. Strategic outlook
    • 7.11.5. SWOT analysis
  • 7.12. Thermo Fisher Scientific Inc.
    • 7.12.1. Business overview
    • 7.12.2. Financial data
    • 7.12.3. Product landscape
    • 7.12.4. Strategic outlook
    • 7.12.5. SWOT analysis

Chapter 8. Company Profiles

  • 8.1. Abbott
    • 8.1.1. Business overview
    • 8.1.2. Financial data
    • 8.1.3. Product landscape
    • 8.1.4. Strategic outlook
    • 8.1.5. SWOT analysis
  • 8.2. Convergent Technologies GmbH & Co. KG
    • 8.2.1. Business overview
    • 8.2.2. Financial data
    • 8.2.3. Product landscape
    • 8.2.4. Strategic outlook
    • 8.2.5. SWOT analysis
  • 8.3. Dalko Diagnostics
    • 8.3.1. Business overview
    • 8.3.2. Financial data
    • 8.3.3. Product landscape
    • 8.3.4. Strategic outlook
    • 8.3.5. SWOT analysis
  • 8.4. Edan Instruments, Inc.
    • 8.4.1. Business overview
    • 8.4.2. Financial data
    • 8.4.3. Product landscape
    • 8.4.4. Strategic outlook
    • 8.4.5. SWOT analysis
  • 8.5. Erba Mannheim
    • 8.5.1. Business overview
    • 8.5.2. Financial data
    • 8.5.3. Product landscape
    • 8.5.4. Strategic outlook
    • 8.5.5. SWOT analysis
  • 8.6. F. Hoffmann-La Roche Ltd.
    • 8.6.1. Business overview
    • 8.6.2. Financial data
    • 8.6.3. Product landscape
    • 8.6.4. Strategic outlook
    • 8.6.5. SWOT analysis
  • 8.7. Instrumentation Laboratory (Werfen)
    • 8.7.1. Business overview
    • 8.7.2. Financial data
    • 8.7.3. Product landscape
    • 8.7.4. Strategic outlook
    • 8.7.5. SWOT analysis
  • 8.8. Medica Corporation
    • 8.8.1. Business overview
    • 8.8.2. Financial data
    • 8.8.3. Product landscape
    • 8.8.4. Strategic outlook
    • 8.8.5. SWOT analysis
  • 8.9. OPTI Medical
    • 8.9.1. Business overview
    • 8.9.2. Financial data
    • 8.9.3. Product landscape
    • 8.9.4. Strategic outlook
    • 8.9.5. SWOT analysis
  • 8.10. Radiometer
    • 8.10.1. Business overview
    • 8.10.2. Financial data
    • 8.10.3. Product landscape
    • 8.10.4. Strategic outlook
    • 8.10.5. SWOT analysis
  • 8.11. Siemens AG
    • 8.11.1. Business overview
    • 8.11.2. Financial data
    • 8.11.3. Product landscape
    • 8.11.4. Strategic outlook
    • 8.11.5. SWOT analysis
  • 8.12. Tecom Analytical Systems
    • 8.12.1. Business overview
    • 8.12.2. Financial data
    • 8.12.3. Product landscape
    • 8.12.4. Strategic outlook
    • 8.12.5. SWOT analysis

Data Tables

  • TABLE 1 Blood gas and electrolyte analyzers (BGEA) industry 360 degree synopsis, 2013 - 2024
  • TABLE 2 BGEA market, 2013-2017 (USD Million)
  • TABLE 3 BGEA market, 2018-2024 (USD Million)
  • TABLE 4 BGEA market, by modality, 2013-2017 (USD Million)
  • TABLE 5 BGEA market, by modality, 2018-2024 (USD Million)
  • TABLE 6 BGEA market, by product, 2013-2017 (USD Million)
  • TABLE 7 BGEA market, by product, 2018-2024 (USD Million)
  • TABLE 8 BGEA market, by end-use, 2013-2017 (USD Million)
  • TABLE 9 BGEA market, by end-use, 2018-2024 (USD Million)
  • TABLE 10 BGEA market, by region, 2013-2017 (USD Million)
  • TABLE 11 BGEA market, by region, 2018-2024 (USD Million)
  • TABLE 12 Industry impact forces
  • TABLE 13 Bench top market size, by region, 2013-2017 (USD Million)
  • TABLE 14 Bench top market size, by region, 2018-2024 (USD Million)
  • TABLE 15 Portable market size, by region, 2013-2017 (USD Million)
  • TABLE 16 Portable market size, by region, 2018-2024 (USD Million)
  • TABLE 17 Blood gas analyzers market size, by region, 2013-2017 (USD Million)
  • TABLE 18 Blood gas analyzers market size, by region, 2018-2024 (USD Million)
  • TABLE 19 Electrolyte analyzers market size, by region, 2013-2017 (USD Million)
  • TABLE 20 Electrolyte analyzers market size, by region, 2018-2024 (USD Million)
  • TABLE 21 Combined analyzers market size, by region, 2013-2017 (USD Million)
  • TABLE 22 Combined analyzers market size, by region, 2018-2024 (USD Million)
  • TABLE 23 Consumables market size, by region, 2013-2017 (USD Million)
  • TABLE 24 Consumables market size, by region, 2018-2024 (USD Million)
  • TABLE 25 Central laboratories market size, by region, 2013-2017 (USD Million)
  • TABLE 26 Central laboratories market size, by region, 2018-2024 (USD Million)
  • TABLE 27 Point-of-care market size, by region, 2013-2017 (USD Million)
  • TABLE 28 Point-of-care market size, by region, 2018-2024 (USD Million)
  • TABLE 29 Diagnostic centers market size, by region, 2013-2017 (USD Million)
  • TABLE 30 Diagnostic centers market size, by region, 2018-2024 (USD Million)
  • TABLE 31 Others market size, by region, 2013-2017 (USD Million)
  • TABLE 32 Others market size, by region, 2018-2024 (USD Million)
  • TABLE 33 North America BGEA market size, by country, 2013-2017 (USD Million)
  • TABLE 34 North America BGEA market size, by country, 2018-2024 (USD Million)
  • TABLE 35 North America BGEA market size, by modality, 2013-2017 (USD Million)
  • TABLE 36 North America BGEA market size, by modality, 2018-2024 (USD Million)
  • TABLE 37 North America BGEA market size, by product, 2013-2017 (USD Million)
  • TABLE 38 North America BGEA market size, by product, 2018-2024 (USD Million)
  • TABLE 39 North America BGEA market size, by end-use, 2013-2017 (USD Million)
  • TABLE 40 North America BGEA market size, by end-use, 2018-2024 (USD Million)
  • TABLE 41 U.S. BGEA market size, by modality, 2013-2017 (USD Million)
  • TABLE 42 U.S. BGEA market size, by modality, 2018-2024 (USD Million)
  • TABLE 43 U.S. BGEA market size, by product, 2013-2017 (USD Million)
  • TABLE 44 U.S. BGEA market size, by product, 2018-2024 (USD Million)
  • TABLE 45 U.S. BGEA market size, by end-use, 2013-2017 (USD Million)
  • TABLE 46 U.S. BGEA market size, by end-use, 2018-2024 (USD Million)
  • TABLE 47 Canada BGEA market size, by modality, 2013-2017 (USD Million)
  • TABLE 48 Canada BGEA market size, by modality, 2018-2024 (USD Million)
  • TABLE 49 Canada BGEA market size, by product, 2013-2017 (USD Million)
  • TABLE 50 Canada BGEA market size, by product, 2018-2024 (USD Million)
  • TABLE 51 Canada BGEA market size, by end-use, 2013-2017 (USD Million)
  • TABLE 52 Canada BGEA market size, by end-use, 2018-2024 (USD Million)
  • TABLE 53 Europe BGEA market size, by country, 2013-2017 (USD Million)
  • TABLE 54 Europe BGEA market size, by country, 2018-2024 (USD Million)
  • TABLE 55 Europe BGEA market size, by modality, 2013-2017 (USD Million)
  • TABLE 56 Europe BGEA market size, by modality, 2018-2024 (USD Million)
  • TABLE 57 Europe BGEA market size, by product, 2013-2017 (USD Million)
  • TABLE 58 Europe BGEA market size, by product, 2018-2024 (USD Million)
  • TABLE 59 Europe BGEA market size, by end-use, 2013-2017 (USD Million)
  • TABLE 60 Europe BGEA market size, by end-use, 2018-2024 (USD Million)
  • TABLE 61 Germany BGEA market size, by modality, 2013-2017 (USD Million)
  • TABLE 62 Germany BGEA market size, by modality, 2018-2024 (USD Million)
  • TABLE 63 Germany BGEA market size, by product, 2013-2017 (USD Million)
  • TABLE 64 Germany BGEA market size, by product, 2018-2024 (USD Million)
  • TABLE 65 Germany BGEA market size, by end-use, 2013-2017 (USD Million)
  • TABLE 66 Germany BGEA market size, by end-use, 2018-2024 (USD Million)
  • TABLE 67 UK BGEA market size, by modality, 2013-2017 (USD Million)
  • TABLE 68 UK BGEA market size, by modality, 2018-2024 (USD Million)
  • TABLE 69 UK BGEA market size, by product, 2013-2017 (USD Million)
  • TABLE 70 UK BGEA market size, by product, 2018-2024 (USD Million)
  • TABLE 71 UK BGEA market size, by end-use, 2013-2017 (USD Million)
  • TABLE 72 UK BGEA market size, by end-use, 2018-2024 (USD Million)
  • TABLE 73 France BGEA market size, by modality, 2013-2017 (USD Million)
  • TABLE 74 France BGEA market size, by modality, 2018-2024 (USD Million)
  • TABLE 75 France BGEA market size, by product, 2013-2017 (USD Million)
  • TABLE 76 France BGEA market size, by product, 2018-2024 (USD Million)
  • TABLE 77 France BGEA market size, by end-use, 2013-2017 (USD Million)
  • TABLE 78 France BGEA market size, by end-use, 2018-2024 (USD Million)
  • TABLE 79 Spain BGEA market size, by modality, 2013-2017 (USD Million)
  • TABLE 80 Spain BGEA market size, by modality, 2018-2024 (USD Million)
  • TABLE 81 Spain BGEA market size, by product, 2013-2017 (USD Million)
  • TABLE 82 Spain BGEA market size, by product, 2018-2024 (USD Million)
  • TABLE 83 Spain BGEA market size, by end-use, 2013-2017 (USD Million)
  • TABLE 84 Spain BGEA market size, by end-use, 2018-2024 (USD Million)
  • TABLE 85 Italy BGEA market size, by modality, 2013-2017 (USD Million)
  • TABLE 86 Italy BGEA market size, by modality, 2018-2024 (USD Million)
  • TABLE 87 Italy BGEA market size, by product, 2013-2017 (USD Million)
  • TABLE 88 Italy BGEA market size, by product, 2018-2024 (USD Million)
  • TABLE 89 Italy BGEA market size, by end-use, 2013-2017 (USD Million)
  • TABLE 90 Italy BGEA market size, by end-use, 2018-2024 (USD Million)
  • TABLE 91 Asia Pacific BGEA market size, by country, 2013-2017 (USD Million)
  • TABLE 92 Asia Pacific BGEA market size, by country, 2018-2024 (USD Million)
  • TABLE 93 Asia Pacific BGEA market size, by modality, 2013-2017 (USD Million)
  • TABLE 94 Asia Pacific BGEA market size, by modality, 2018-2024 (USD Million)
  • TABLE 95 Asia Pacific BGEA market size, by product, 2013-2017 (USD Million)
  • TABLE 96 Asia Pacific BGEA market size, by product, 2018-2024 (USD Million)
  • TABLE 97 Asia Pacific BGEA market size, by end-use, 2013-2017 (USD Million)
  • TABLE 98 Asia Pacific BGEA market size, by end-use, 2018-2024 (USD Million)
  • TABLE 99 India BGEA market size, by modality, 2013-2017 (USD Million)
  • TABLE 100 India BGEA market size, by modality, 2018-2024 (USD Million)
  • TABLE 101 India BGEA market size, by product, 2013-2017 (USD Million)
  • TABLE 102 India BGEA market size, by product, 2018-2024 (USD Million)
  • TABLE 103 India BGEA market size, by end-use, 2013-2017 (USD Million)
  • TABLE 104 India BGEA market size, by end-use, 2018-2024 (USD Million)
  • TABLE 105 China BGEA market size, by modality, 2013-2017 (USD Million)
  • TABLE 106 China BGEA market size, by modality, 2018-2024 (USD Million)
  • TABLE 107 China BGEA market size, by product, 2013-2017 (USD Million)
  • TABLE 108 China BGEA market size, by product, 2018-2024 (USD Million)
  • TABLE 109 China BGEA market size, by end-use, 2013-2017 (USD Million)
  • TABLE 110 China BGEA market size, by end-use, 2018-2024 (USD Million)
  • TABLE 111 Japan BGEA market size, by modality, 2013-2017 (USD Million)
  • TABLE 112 Japan BGEA market size, by modality, 2018-2024 (USD Million)
  • TABLE 113 Japan BGEA market size, by product, 2013-2017 (USD Million)
  • TABLE 114 Japan BGEA market size, by product, 2018-2024 (USD Million)
  • TABLE 115 Japan BGEA market size, by end-use, 2013-2017 (USD Million)
  • TABLE 116 Japan BGEA market size, by end-use, 2018-2024 (USD Million)
  • TABLE 117 Latin America BGEA market size, by country, 2013-2017 (USD Million)
  • TABLE 118 Latin America BGEA market size, by country, 2018-2024 (USD Million)
  • TABLE 119 Latin America BGEA market size, by modality, 2013-2017 (USD Million)
  • TABLE 120 Latin America BGEA market size, by modality, 2018-2024 (USD Million)
  • TABLE 121 Latin America BGEA market size, by product, 2013-2017 (USD Million)
  • TABLE 122 Latin America BGEA market size, by product, 2018-2024 (USD Million)
  • TABLE 123 Latin America BGEA market size, by end-use, 2013-2017 (USD Million)
  • TABLE 124 Latin America BGEA market size, by end-use, 2018-2024 (USD Million)
  • TABLE 125 Brazil BGEA market size, by modality, 2013-2017 (USD Million)
  • TABLE 126 Brazil BGEA market size, by modality, 2018-2024 (USD Million)
  • TABLE 127 Brazil BGEA market size, by product, 2013-2017 (USD Million)
  • TABLE 128 Brazil BGEA market size, by product, 2018-2024 (USD Million)
  • TABLE 129 Brazil BGEA market size, by end-use, 2013-2017 (USD Million)
  • TABLE 130 Brazil BGEA market size, by end-use, 2018-2024 (USD Million)
  • TABLE 131 Mexico BGEA market size, by modality, 2013-2017 (USD Million)
  • TABLE 132 Mexico BGEA market size, by modality, 2018-2024 (USD Million)
  • TABLE 133 Mexico BGEA market size, by product, 2013-2017 (USD Million)
  • TABLE 134 Mexico BGEA market size, by product, 2018-2024 (USD Million)
  • TABLE 135 Mexico BGEA market size, by end-use, 2013-2017 (USD Million)
  • TABLE 136 Mexico BGEA market size, by end-use, 2018-2024 (USD Million)
  • TABLE 137 MEA BGEA market size, by country, 2013-2017 (USD Million)
  • TABLE 138 MEA BGEA market size, by country, 2018-2024 (USD Million)
  • TABLE 139 MEA BGEA market size, by modality, 2013-2017 (USD Million)
  • TABLE 140 MEA BGEA market size, by modality, 2018-2024 (USD Million)
  • TABLE 141 MEA BGEA market size, by product, 2013-2017 (USD Million)
  • TABLE 142 MEA BGEA market size, by product, 2018-2024 (USD Million)
  • TABLE 143 MEA BGEA market size, by end-use, 2013-2017 (USD Million)
  • TABLE 144 MEA BGEA market size, by end-use, 2018-2024 (USD Million)
  • TABLE 145 South Africa BGEA market size, by modality, 2013-2017 (USD Million)
  • TABLE 146 South Africa BGEA market size, by modality, 2018-2024 (USD Million)
  • TABLE 147 South Africa BGEA market size, by product, 2013-2017 (USD Million)
  • TABLE 148 South Africa BGEA market size, by product, 2018-2024 (USD Million)
  • TABLE 149 South Africa BGEA market size, by end-use, 2013-2017 (USD Million)
  • TABLE 150 South Africa BGEA market size, by end-use, 2018-2024 (USD Million)
  • TABLE 151 Saudi Arabia BGEA market size, by modality, 2013-2017 (USD Million)
  • TABLE 152 Saudi Arabia BGEA market size, by modality, 2018-2024 (USD Million)
  • TABLE 153 Saudi Arabia BGEA market size, by product, 2013-2017 (USD Million)
  • TABLE 154 Saudi Arabia BGEA market size, by product, 2018-2024 (USD Million)
  • TABLE 155 Saudi Arabia BGEA market size, by end-use, 2013-2017 (USD Million)
  • TABLE 156 Saudi Arabia BGEA market size, by end-use, 2018-2024 (USD Million)

Charts & Figures

  • FIG. 1 Industry segmentation
  • FIG. 2 Global blood gas and electrolyte analyzers market, 2013 - 2024 (USD Million)
  • FIG. 3 Growth potential analysis, by product
  • FIG. 4 Growth potential analysis, by modality
  • FIG. 5 Growth potential analysis, by end-use
  • FIG. 6 Porter's analysis
  • FIG. 7 Strategy dashboard
  • FIG. 8 PESTEL analysis